Strengthening voluntary non-remunerated plasma collection capacity in Europe
About Us
What is SUPPLY?
SUPPLY is a project co-funded by the European Union’s EU4Health Programme that aims to increase and strengthen the resilience of plasma collection in the EU to enable a stable and adequate supply of Plasma-derived medicinal products (PDMPs). The entire plasma chain is assessed – from plasma donor recruitment, retention, and health, through plasma collection and processing, to demand and use of PDMPs.
Now is the time…
..for policymakers, healthcare providers, and stakeholders to consider the guidance provided and work collaboratively to achieve optimal availability of plasma medicines for patients.
..to examine the recommendations provided in SUPPLY to increase plasma collection in the EU by the public health sector to ensure a sufficient, adequate, and resilient supply of plasma and to contribute to European self-sufficiency.
..to review the recommendations and guidance provided and implement the measures required to ensure the plasma and PDMP system is robust and resilient now and in the next times of crisis.
..to act in the interests of patients, donors, and all EU citizens.
Key Take-Aways
- Focus on retaining donors while building a sustainable donor base
- Carry out a large prospective study in plasma donors to examine the health consequences of plasma donation at varying frequencies
- Take consideration of the IgG level to determine the value of plasma
- Invest in the increase and improvement of the plasma collection – EU Member States, create action plans!
- Introduce legal provisions at national level which link collected plasma to the usage of products manufactured from this plasma by the public health sector
- Create national databases on Ig usage at patient level
- Need for an EU wide harmonized management plan on shortages
- Continue to collaborate!
Who are we?
The SUPPLY project, led by the European Blood Alliance, was carried out by a large European consortium of 13 Beneficiaries and 6 Associated Partners with broad and complementary expertise relating to all aspects of blood and plasma collection, processing, and medicinal use.
Latest News
6th ECDHM
Results and outputs from the SUPPLY project featured throughout the 6th European Conference on Donor Health and management (ECDHM 2025), co-organised by Sanquin and the European Blood Alliance. The full program and abstract book can be accessed here:...
Study on Plasma Donation Frequency
Arising out of the SUPPLY analysis of the literature on frequent plasmapheresis, ISBT’s Transfusion Today magazine published ‘Building the evidence base to protect plasma donors: Why Europe needs a large, multicentre randomised controlled trial on plasma donation...
Commit to Plasma Campaign
The Commit to Plasma campaign involves patient groups, donors, blood establishments, physicians and other healthcare professionals, hospitals, healthcare services, and public sector industry representatives working together to urge national and EU authorities to...
SUPPLY’s impact continues
Two linked articles have just been published in Vox Sanguinis showing that dependence on US Plasma can be offset by publicly collected plasma, which may be converted into PDMPs under contracts that return the products to the public health system. Achieving strategic...
Balancing donor health and plasma collection: Publication
August 21, 2024 Our SUPPLY WP5 Team has published Balancing donor health and plasma collection: a systematic review of the impact of plasmapheresis frequency in Transfusion Medicine Reviews. Recognising that donor protection is essential, the team shows that more...